Human DICER helicase domain recruits PKR and modulates its antiviral activity

PLoS Pathog. 2021 May 13;17(5):e1009549. doi: 10.1371/journal.ppat.1009549. eCollection 2021 May.

Abstract

The antiviral innate immune response mainly involves type I interferon (IFN) in mammalian cells. The contribution of the RNA silencing machinery remains to be established, but several recent studies indicate that the ribonuclease DICER can generate viral siRNAs in specific conditions. It has also been proposed that type I IFN and RNA silencing could be mutually exclusive antiviral responses. In order to decipher the implication of DICER during infection of human cells with alphaviruses such as the Sindbis virus and Semliki forest virus, we determined its interactome by proteomics analysis. We show that DICER specifically interacts with several double-stranded RNA binding proteins and RNA helicases during viral infection. In particular, proteins such as DHX9, ADAR-1 and the protein kinase RNA-activated (PKR) are enriched with DICER in virus-infected cells. We demonstrate that the helicase domain of DICER is essential for this interaction and that its deletion confers antiviral properties to this protein in an RNAi-independent, PKR-dependent, manner.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alphavirus Infections / drug therapy*
  • Alphavirus Infections / metabolism
  • Alphavirus Infections / pathology
  • Antiviral Agents / pharmacology*
  • DEAD-box RNA Helicases / genetics
  • DEAD-box RNA Helicases / metabolism*
  • HEK293 Cells
  • Humans
  • Interferon Type I / pharmacology
  • Protein Interaction Domains and Motifs / drug effects*
  • Ribonuclease III / genetics
  • Ribonuclease III / metabolism*
  • Semliki forest virus / drug effects*
  • Virus Replication*
  • eIF-2 Kinase / genetics
  • eIF-2 Kinase / metabolism*

Substances

  • Antiviral Agents
  • Interferon Type I
  • EIF2AK2 protein, human
  • eIF-2 Kinase
  • DICER1 protein, human
  • Ribonuclease III
  • DEAD-box RNA Helicases

Grants and funding

This work was funded by the European Research Council (ERC-CoG-647455 RegulRNA) (to SP) and was performed under the framework of the LABEX: ANR-10-LABX-0036_NETRNA (to SP) and ANR-17-EURE-0023 (to SP), which benefits from a funding from the state managed by the French National Research Agency as part of the Investments for the future program. This work has also received funding from the People Programme (Marie Curie Actions) of the European Union’s Seventh Framework Program (FP7/2007-2013) under REA grant agreement n° PCOFUND-GA-2013-609102, through the PRESTIGE program coordinated by Campus France (to EG), and from the French Minister for Higher Education, Research and Innovation (to MB). The mass spectrometry instrumentation was funded by the University of Strasbourg, IdEx “Equipement mi-lourd” 2015 (to PH). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.